CME asks court to dismiss shareholder lawsuit against merger with NYMEX

摘要

CME Group on Monday asked the Delaware Court of Chancery to dismiss a lawsuit aimed at stopping the merger between CME and NYMEX Holdings, saying there were no "well-pled facts" to the charges.rnThree NYMEX shareholders named CME in an amended, consolidated lawsuit after CME filed what plaintiffs called a "misleading and incomplete" preliminary proxy on the proposed merger filed June 10 with the Securities and Exchange Commission. The suit says that based on the information provided in the proxy statement, NYMEX shareholders cannot make an informed decision on whether or not to approve the proposed acquisition.rnCME's motion for dismissal was made in the name of CMEG NY Inc., the name NYMEX - as a wholly owned subsidiary of CME - would assume once the merger is complete. CME's motion argued that proxy amendments could make moot any purported deficiencies in the preliminary document.